Empire Asset Assigns Penny Stock Lipocine $21 Price Target, Buy Rating
Benzinga Lipocine decided to initiate FDA-requested trials addressing blood pressure and phlebotomy concerns ahead of the extended May 8 Prescription Drug User Fee Act date. Reese, who acknowledged rumors that Lipocine was investigating the validity of such ... |
from phlebotomy - Google News http://bit.ly/2otoEfk
No comments:
Post a Comment